BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23498041)

  • 1. Antiretroviral treatment uptake in patients with HIV-associated TB attending co-located TB and ART services.
    Nglazi MD; Kaplan R; Caldwell J; Peton N; Lawn SD; Wood R; Bekker LG
    S Afr Med J; 2012 Oct; 102(12):936-9. PubMed ID: 23498041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township.
    Lawn SD; Campbell L; Kaplan R; Little F; Morrow C; Wood R;
    BMC Infect Dis; 2011 Sep; 11():258. PubMed ID: 21957868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study.
    Nglazi MD; Bekker LG; Wood R; Kaplan R
    BMC Infect Dis; 2015 Nov; 15():536. PubMed ID: 26584607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland.
    Pathmanathan I; Pasipamire M; Pals S; Dokubo EK; Preko P; Ao T; Mazibuko S; Ongole J; Dhlamini T; Haumba S
    PLoS One; 2018; 13(5):e0196831. PubMed ID: 29768503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study.
    Kerschberger B; Hilderbrand K; Boulle AM; Coetzee D; Goemaere E; De Azevedo V; Van Cutsem G
    PLoS One; 2012; 7(10):e46988. PubMed ID: 23071690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study.
    Herce ME; Morse J; Luhanga D; Harris J; Smith HJ; Besa S; Samungole G; Kancheya N; Muyoyeta M; Reid SE
    BMC Infect Dis; 2018 Oct; 18(1):536. PubMed ID: 30367622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa.
    Pepper DJ; Marais S; Wilkinson RJ; Bhaijee F; De Azevedo V; Meintjes G
    PLoS One; 2011 May; 6(5):e19484. PubMed ID: 21589868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011).
    Kaplan R; Caldwell J; Middelkoop K; Bekker LG; Wood R
    J Acquir Immune Defic Syndr; 2014 Aug; 66(5):487-94. PubMed ID: 24820105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.
    Lawn SD; Myer L; Bekker LG; Wood R
    AIDS; 2007 Jan; 21(3):335-41. PubMed ID: 17255740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Timing of Initiation of Antiretroviral Therapy on Loss to Follow-up in HIV-Tuberculosis Coinfected Patients in South Africa: An Open-Label, Randomized, Controlled Trial.
    Yende-Zuma N; Naidoo K
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):430-6. PubMed ID: 26990824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa.
    Lawn SD; Campbell L; Kaplan R; Boulle A; Cornell M; Kerschberger B; Morrow C; Little F; Egger M; Wood R;
    J Acquir Immune Defic Syndr; 2011 Jun; 57(2):136-40. PubMed ID: 21436714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa.
    Bassett IV; Chetty S; Wang B; Mazibuko M; Giddy J; Lu Z; Walensky RP; Freedberg KA; Losina E
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):25-30. PubMed ID: 22027877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi.
    Kumwenda M; Tom S; Chan AK; Mwinjiwa E; Sodhi S; Joshua M; van Lettow M
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1663-9. PubMed ID: 22118175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral outcomes in South African prisoners: a retrospective cohort analysis.
    Davies NE; Karstaedt AS
    PLoS One; 2012; 7(3):e33309. PubMed ID: 22470448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database.
    Han SH; Zhou J; Lee MP; Zhao H; Chen YM; Kumarasamy N; Pujari S; Lee C; Omar SF; Ditangco R; Phanuphak N; Kiertiburanakul S; Chaiwarith R; Merati TP; Yunihastuti E; Tanuma J; Saphonn V; Sohn AH; Choi JY;
    HIV Med; 2014 Feb; 15(2):77-85. PubMed ID: 23980589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.
    Evans D; Takuva S; Rassool M; Firnhaber C; Maskew M
    J Neurovirol; 2012 Jun; 18(3):162-71. PubMed ID: 22528477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to and enablers of uptake of and adherence to antiretroviral therapy in the context of integrated HIV and tuberculosis treatment among adults in sub-Saharan Africa: a protocol for a systematic literature review.
    Momo Kadia B; Takah NF; Akem Dimala C; Smith A
    BMJ Open; 2019 Oct; 9(10):e031789. PubMed ID: 31662398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town.
    Kaplan R; Hermans S; Caldwell J; Jennings K; Bekker LG; Wood R
    BMC Infect Dis; 2018 Jul; 18(1):356. PubMed ID: 30064368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.
    Tweya H; Feldacker C; Mpunga J; Kanyerere H; Heller T; Ganesh P; Nkosi D; Kalulu M; Sinkala G; Satumba T; Phiri S
    J Int AIDS Soc; 2019 Apr; 22(4):e25240. PubMed ID: 31038836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
    Schnippel K; Berhanu RH; Black A; Firnhaber C; Maitisa N; Evans D; Sinanovic E
    BMC Infect Dis; 2016 Oct; 16(1):593. PubMed ID: 27769174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.